What Is a Lexiscan: Uses, Risks, and What to Expect

Lexiscan is the brand name for regadenoson, a drug injected into a vein to temporarily widen your coronary arteries so doctors can take images of blood flow through your heart. It is used during a type of cardiac stress test called myocardial perfusion imaging, or MPI, and it serves as a stand-in for exercise when a patient cannot walk on a treadmill fast enough to raise their heart rate to the target level. The test itself typically takes a few hours from start to finish, with the actual drug injection lasting only about ten seconds, and while side effects like flushing, headache, and shortness of breath are common, they usually fade within minutes.

Why Some People Need a Drug Instead of a Treadmill

The standard way to stress-test a heart is to have a patient walk or jog on a treadmill until their heart rate climbs high enough to reveal whether any coronary arteries are narrowed. But a surprising number of people referred for cardiac testing simply cannot exercise hard enough. Severe arthritis, peripheral vascular disease, chronic lung conditions, obesity, amputation, recent surgery, or advanced age can all make a treadmill test impractical or unsafe. For these patients, a pharmacologic stress agent like Lexiscan mimics the effect of exercise on blood flow without requiring a single step.

The drug works by targeting a specific receptor on the smooth muscle cells that line coronary arteries. When regadenoson binds to that receptor, the arteries relax and dilate, dramatically increasing blood flow to the heart muscle. Healthy arteries open wide; arteries narrowed by plaque cannot open as much. A radioactive tracer injected alongside the drug travels through the bloodstream and collects in heart tissue in proportion to blood flow. A special camera then captures images showing which parts of the heart received good blood supply and which did not. The contrast between well-perfused and under-perfused areas is what tells your cardiologist whether coronary artery disease is present.

What Happens on the Day of the Test

A Lexiscan stress test is an outpatient procedure. You’ll arrive at a nuclear cardiology lab, get an IV line placed, and have electrodes attached to your chest for continuous heart-rhythm monitoring. The process generally unfolds in two phases: a rest phase and a stress phase, though the order can vary by lab.

During the rest phase, the technologist injects a small dose of radioactive tracer through your IV and, after a waiting period for the tracer to circulate, takes a set of images while you lie still under a gamma camera. During the stress phase, regadenoson is pushed through the IV as a rapid injection, and peak coronary dilation occurs roughly 70 seconds later. The tracer is injected at or near that peak, and a second round of imaging follows after another waiting period. Comparing the two image sets reveals whether blood flow looks normal at rest but drops off under stress, the hallmark of a significant blockage.

Total time in the lab averages around two and a half hours with regadenoson, which is shorter than the older pharmacologic agents adenosine and dipyridamole. A study comparing all three found that regadenoson shaved roughly 14 minutes off the pre-imaging portion of the test compared to adenosine and about 12 minutes compared to dipyridamole, largely because regadenoson is a single quick push rather than a multi-minute infusion that requires weight-based dosing calculations.¹ That convenience is one reason regadenoson has become the dominant pharmacologic stress agent in the United States.

Common Side Effects and How They Feel

Most people feel something after the injection, and it can be startling if you are not prepared. In clinical trials involving patients with chronic kidney disease (a large group that frequently undergoes this test), the most reported side effects with regadenoson compared to placebo were headache (about a quarter of patients), shortness of breath (roughly one in five), chest discomfort, nausea, flushing, and dizziness.² Heart rate typically rises by about 25 to 30 beats per minute, and blood pressure can swing in either direction.

The chest tightness people describe during the test is usually not angina from a blockage but a direct effect of the drug on adenosine receptors in the lungs and chest wall. It tends to peak within a minute or two and fades on its own. Many patients also report a warm, flushed feeling that spreads through the body, along with a brief sensation that breathing is more labored than normal. All of these effects generally resolve within 10 to 15 minutes without any treatment, though the lab team monitors you continuously and can intervene if needed.

The Caffeine Rule and Why It Matters

If you are scheduled for a Lexiscan test, your doctor’s office will tell you to stop consuming caffeine for at least 12 hours beforehand, and many labs ask for 24 hours. The reason is that caffeine is a natural adenosine-receptor blocker, and since regadenoson works by activating one of those receptors, caffeine in your system could blunt the drug’s ability to dilate your coronary arteries. Research has confirmed that caffeine shortens the duration of the coronary blood-flow increase that regadenoson produces.³

That said, the practical question of how much caffeine actually ruins the test has been debated. Patients are routinely told to abstain, and failing to do so often means the test gets cancelled or postponed, which can cause real scheduling headaches.⁴ A study that grouped patients by their coffee habits found that people who drank coffee 12 to 24 hours before the test showed slightly smaller heart-rate and blood-pressure responses compared to non-coffee drinkers, though the differences were modest.⁵ Still, the standard advice remains to avoid coffee, tea, chocolate, energy drinks, and caffeinated sodas in the window your lab specifies. It is a minor inconvenience that can save you from having to repeat the entire test.

Beyond caffeine, you will also typically be told to stop certain medications, particularly those containing theophylline or dipyridamole, which can interact with regadenoson. Your lab should give you a specific list. Most people are asked to avoid eating for a few hours before the test as well, since nausea is a common side effect and an empty stomach makes it more manageable.

Serious but Rare Complications

Regadenoson has a strong overall safety record, but like all pharmacologic stress agents, it carries some real risks that go beyond discomfort. Understanding these helps put the common side effects in perspective: feeling flushed and short of breath is expected and harmless, but a small number of patients experience reactions that require immediate medical attention.

Heart-rhythm disturbances are the most clinically significant concern. Case reports have documented advanced heart block and even asystole (a complete loss of heart electrical activity) following regadenoson injection. One published case involved an 84-year-old man who developed second-degree heart block progressing to pulseless electrical activity and asystole after the drug was given.⁶ These events remain rare, and labs are equipped with crash carts and resuscitation protocols for exactly this scenario, but they are the reason the test is performed under medical supervision with continuous ECG monitoring.

Seizures are another uncommon but recognized adverse event. As of mid-2018, a total of 148 seizure cases and 10 seizure-like episodes had been reported to the FDA in connection with regadenoson, though the total number of patients exposed to the drug and their prior seizure histories were not included in those reports, making it difficult to pin down a true rate.⁷ This risk is worth knowing about, especially if you have a history of seizures, because your doctor may choose an alternative stress method.

For patients with asthma or chronic obstructive pulmonary disease (COPD), the worry has been that stimulating adenosine receptors could trigger dangerous bronchoconstriction. A large randomized, placebo-controlled trial specifically enrolling people with asthma or COPD found that the rate of a meaningful drop in lung function was not significantly different between the regadenoson and placebo groups. No patients in that trial experienced severe bronchoconstriction, though the researchers cautioned that the possibility cannot be ruled out entirely and that caution is still warranted.⁸

How Side Effects Are Reversed

One practical advantage of pharmacologic stress testing is that if you are feeling terrible after the injection, the medical team can often make the symptoms go away quickly. The standard antidote is aminophylline, an intravenous drug that blocks the same adenosine receptors regadenoson has activated. A study that randomized patients to receive either IV aminophylline, IV caffeine citrate, or oral caffeine (as coffee or diet cola) found that all three approaches reversed symptoms effectively, with complete or predominant reversal occurring in about 99% of cases. Complete reversal rates were similar for IV aminophylline and IV caffeine (both around 87%), while oral caffeine was somewhat less effective at achieving full reversal. When reversal worked, symptoms resolved in an average of about two and a half minutes.⁹

An important separate question is whether giving aminophylline after the tracer has been injected could erase the diagnostic information the test is trying to capture. A study that randomly assigned patients to receive aminophylline or placebo after their stress images found no difference in the amount of ischemia detected or in outcomes like heart attack or the need for later procedures.¹⁰ In other words, reversing your discomfort does not appear to compromise the accuracy of the test, as long as the tracer has already been distributed to the heart muscle before the reversal agent is given.

People with Kidney Disease

Regadenoson is cleared from the body primarily through the kidneys, which raises an obvious question for people whose kidneys are not working well. This population is large and clinically important, because kidney disease and heart disease often travel together, and these patients frequently need cardiac stress testing.

A focused review of the evidence found that post-marketing research has examined regadenoson’s behavior in patients with chronic kidney disease and end-stage renal disease, ultimately leading to a label update for the drug.¹¹ In a randomized trial of patients with stage 3 or 4 chronic kidney disease, regadenoson produced no serious adverse events or deaths within 24 hours, and there were no clinically meaningful changes in kidney function after the test.² Side effects were more common than in people on placebo, with the same profile of headache, shortness of breath, and flushing seen in the general population, but the drug did not appear to further damage already-compromised kidneys.

For patients on dialysis, one concern is that side effects may last longer because the drug is not being filtered out as quickly. Case reports have noted that late administration of aminophylline can still effectively reverse lingering symptoms in patients with end-stage renal disease.¹² The lab team should be aware of your kidney status before the test so they can plan accordingly.

Walking During a Pharmacologic Stress Test

Even though Lexiscan exists for people who cannot exercise adequately, some labs use a hybrid approach: you receive the regadenoson injection while walking slowly on a treadmill at a low level. This is not meant to replace the drug’s effect on blood flow but rather to reduce side effects and improve image quality. Physical activity helps clear the radioactive tracer from the gut and liver, which sit near the heart and can obscure the images.

A review of initial clinical experience with over 1,200 patients found that shortness of breath, dizziness, palpitations, transient heart block, and nausea were all less frequent in patients who were able to do some walking compared to those who sat still.¹³ If you are able to walk at a slow pace, even if you cannot reach a target heart rate on your own, ask whether a combined protocol is available at your testing facility. It tends to make the experience more tolerable.

How Accurate Is the Test

A pharmacologic stress test is generally considered a reliable way to detect significant coronary artery disease, but it is not perfect. One comparison of regadenoson-based imaging versus treadmill exercise imaging found that the treadmill had a lower false-positive rate (about 24% versus 35% for regadenoson) and a higher positive predictive value (77% versus 65%).¹⁴ In plainer terms, a regadenoson scan is somewhat more likely to flag a problem that turns out not to be there on further testing. That does not make the test unreliable, but it is one reason cardiologists prefer a treadmill test when a patient can actually do one. The pharmacologic route is a fallback for patients who cannot exercise, and in that population, it remains far better than no stress test at all.

In terms of how regadenoson stacks up against the other pharmacologic agents, imaging research comparing it to adenosine found that the two produce equivalent coronary vasodilation, and both were superior to dipyridamole.¹⁵ Regadenoson’s practical edge over adenosine comes down to convenience: a fixed-dose single injection versus a weight-adjusted multi-minute infusion, shorter total procedure time, and a side-effect profile that many patients find more tolerable.

What to Do After the Test

Once your imaging is complete and the medical team is satisfied that you are feeling well, you can usually go home the same day. There is no sedation involved, so you can drive yourself unless a side effect like dizziness lingers. Drinking plenty of water afterward helps flush both the residual regadenoson and the radioactive tracer from your system faster. The tracer delivers a very small radiation dose and decays quickly; it does not pose a meaningful risk to you or to people around you.

Most people feel completely back to normal within an hour of leaving the lab. If you had significant side effects that were reversed with aminophylline or caffeine, you may feel slightly jittery or notice a mild headache afterward. Some patients report feeling unusually tired for the rest of the day, which is more common in people with kidney disease whose bodies take longer to clear the drug. If you experience chest pain, severe shortness of breath, or an irregular heartbeat after you leave, contact your doctor or go to an emergency department, though delayed serious reactions are extremely uncommon.

Results are typically reviewed by a nuclear cardiologist and sent to your referring physician within a few business days. A normal scan is reassuring that the major coronary arteries are supplying blood adequately under stress. An abnormal scan does not automatically mean you need a procedure; it means further evaluation, which could range from additional imaging to a coronary angiogram, depending on the severity and location of the findings and your overall clinical picture.